Rein Therapeutics(RNTX)
AUSTIN, TXBiotechnology
Focus: Rein Therapeutics is a public biotech company focused on perpetually active peptides across nephrology, respiratory, and oncology indications. With 5,000+ employees, the company operates at mid-cap scale but faces critical financial headwinds.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
About Rein Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Rein Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$0K
Pipeline & Clinical Trials
Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients
Patients Reported OutcomesClinical Trials (1)
NCT05154708Impact of the Routine Collection of Symptoms on Quality of Life in Dialysis Patients
N/AHelp build intelligence for Rein Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.